Search results
Intercept Pharmaceuticals (ICPT) Surges on Acquisition Deal
Zacks via Yahoo Finance· 9 months agoShares of Intercept Pharmaceuticals, Inc. ICPT soared 79.2% after Italy-based pharmaceutical company...
Intercept (ICPT) Ocaliva Drives Growth, Pipeline Setbacks Hurt
Zacks via Yahoo Finance· 2 years agoIntercept (ICPT) currently has only one marketed product in its portfolio, Ocaliva, for treating...
Intercept (ICPT) Q4 Earnings Beat, Ocaliva Sales Increase
Zacks via Yahoo Finance· 1 year agoShares of Intercept Pharmaceuticals, Inc. ICPT rose 3.89% on Mar 2 after the company reported...
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoIntercept Pharmaceuticals, Inc. (NASDAQ:ICPT) Q4 2022 Earnings Call Transcript March 2, 2023...
Intercept (ICPT) Settles Litigation With Dr. Reddy's for Ocaliva
Zacks via Yahoo Finance· 2 years agoShares of Intercept Pharmaceuticals, Inc. ICPT were up 3.65% on Aug 17 after the company announced a...
Intercept Settles Ocaliva Litigation With Reddy's Lab
Benzinga via Yahoo Finance· 2 years agoIntercept Pharmaceuticals Inc (NASDAQ: ICPT) and its subsidiary Intercept Pharma Europe Limited...
Intercept Surges To Four-Month High After Staving Off Amneal's Generic For 11 Years
Investor's Business Daily· 1 year agoIntercept Pharmaceuticals reached a settlement with Amneal Pharmaceuticals that delays a generic...
Intercept Pharmaceuticals Crashes After Drug Fails In Cirrhotic Patients
Investor's Business Daily· 2 years agoIntercept Pharmaceuticals' experimental NASH treatment failed in patients with liver cirrhosis,...
Why Intercept Pharmaceuticals Stock Is Soaring Today
Motley Fool· 2 years agoShares of Intercept Pharmaceuticals (NASDAQ: ICPT) were soaring 15.7% higher as of 12:02 p.m. ET on Tuesday. It also easily topped the average analysts'...
Intercept (ICPT) Q2 Earnings Top Estimates, Revenues Up Y/Y
Zacks via Yahoo Finance· 11 months agoIntercept (ICPT) reports a lower net loss and beats on revenues in the second quarter. The company...